The following discussion and analysis should be read in conjunction with the Company's unaudited condensed consolidated financial statements and notes thereto included in Part 1, Item 1 of this quarterly report on Form 10-Q and "Management's Discussion and Analysis of Financial Condition and Results of Operations" set forth in the Company's Annual report on Form 10-K for the fiscal year ended December 31, 2019.





Overview


The Company is a leading supplier of digital transaction management (DTM) software enabling the paperless, secure and cost-effective management of document-based transactions. iSign's solutions encompass a wide array of functionality and services, including electronic signatures, biometric authentication and simple-to-complex workflow management. These solutions are available across virtually all enterprise, desktop and mobile environments as a seamlessly integrated platform for both ad-hoc and fully automated transactions. iSign's software platform can be deployed both on-premise and as a cloud-based service, with the ability to easily transition between deployment models.

The Company was incorporated in Delaware in October 1986. Except for the year ended December 31, 2004, in each year since its inception the Company has incurred losses. For the two-year period ended December 31, 2019, net losses aggregated $2,113, and, at September 30, 2020, the Company's accumulated deficit was $134,975.

For the three months ended September 30, 2020, total revenue was $242, an increase of $29, or 14%, compared to total revenue of $213 in the prior year period. For the nine months ended September 30, 2020, total revenue was $659, an increase of $21, or 3%, compared to total revenue of $638 in the prior year period. The increases in revenue for the three and nine months ended September 30, 2020 are due primarily to increases in product and maintenance revenue compared to the prior year periods.

For the three months ended September 30, 2020, the Company recorded a net loss of $30, a decrease of $243, or 89%, compared to a net loss of $273 in the prior year period. The $30 net loss was primarily due to warrant expense related to long-term liabilities of $323 and an increase in interest expense on the increase in debt. These increased expenses were partially offset by $373 in forgiveness of debt resulting from settlement agreements with vendors for outstanding accounts payable balances during the three months ended September 30, 2020. For the nine months ended September 30, 2020 the net loss was $550, a decrease of $263, or 32%, compared to a net loss of $813 in the prior year period.





                                     - 13 -





                              iSign Solutions Inc.

                    (In thousands, except per share amounts)

                                   FORM 10-Q


Critical Accounting Policies and Estimates

Refer to Item 7, "Management Discussion and Analysis of Financial Condition and Results of Operations" in the Company's 2019 Form 10-K.

Effect of Recent Accounting Pronouncements

Accounting Standards Updates issued in 2020 are being evaluated by the Company, however, implementation is not expected to have a material impact on the Company's financial position, results of operations and cash flows.





Results of Operations



Revenue


For the three months ended September 30, 2020, product revenue was $44, a decrease of $1, or 2%, compared to product revenue of $45 in the prior year period. The decrease was primarily due to the timing of new product orders received in the quarter. For the three months ended September 30, 2020, maintenance revenue was $198, an increase of $30, or 18%, compared to maintenance revenue of $168 in the prior year period. The increase is primarily due to an increases in the amount of certain maintenance contract renewals and adjustments.

For the nine months ended September 30, 2020, product revenue was $134, an increase of $8, or 6%, compared to product revenue of $126 in the prior year period. The increase in product revenue is primarily attributable to an increase in engineering project billings compared to the prior year period. For the nine months ended September 30, 2020, maintenance revenue was $525, an increase of $13, or 3%, compared to maintenance revenue of $512 in the prior year period. The increase in maintenance revenue is primarily due to the factors discussed for the three-month period above.





Cost of Sales


For the three months ended September 30, 2020, cost of sales was $29, a decrease of $1, or 4%, compared to cost of sales of $28 in the prior year period. The decrease in cost of sales was primarily due to a decrease in direct labor costs associated with billable engineering revenue partially offset by an increase in labor related to maintenance contracts during the three months ended September 30, 2020, compared to the prior year period.

For the nine months ended September 30, 2020, cost of sales was $86, an increase of $22, or 34%, compared to cost of sales of $64 in the prior year period. The increase in cost of sales was due to an increase in direct labor related to maintenance contracts and billable engineering revenue compared to the prior year period.





Operating expenses



Research and Development Expenses

For the three months ended September 30, 2020, research and development expense was $126, a decrease of $53, or 30%, compared to research and development expense of $179 in the prior year period. Research and development expenses consist primarily of salaries and related costs, outside engineering, maintenance items, and allocated facilities expenses. Research and development expenses decreased primarily due a decrease in outside engineering costs and an increase in the amount of engineering costs allocated to cost of sales. Total expenses, before allocations for the three months ended September 30, 2020, were $172, a decrease of $39, or 18%, compared to $211 in the prior year period. The decrease was primarily due to the reduced outside engineering expense during the current quarter.





                                     - 14 -





                              iSign Solutions Inc.

                    (In thousands, except per share amounts)

                                   FORM 10-Q


Research and Development Expenses (continued)

For the nine months ended September 30, 2020, research and development expense was $446, a decrease of $85, or 16%, compared to research and development expense of $531 in the prior year period. The most significant factors in the decrease include a decrease in stock option expense and other overhead expense, including outside engineering and allocated engineering expense to cost of sales. Total expenses, before allocations to cost of sales, for the nine months ended September 30, 2020, were $545, a decrease of $59, or 10%, compared to $605 in the prior year period. The decrease in total engineering expense is primarily due to the factors discussed for the three month period above.





Sales and Marketing Expense


For the three months ended September 30, 2020, sales and marketing expense was $10, compared to sales and marketing expense of $10 in the prior year period. For the nine months ended September 30, 2020, sales and marketing expense was $62, a decrease of $1, or 2%, compared to sales and marketing expense of $63 in the prior year period. These decrease was primarily attributable to a decrease in commissions compared to the prior year period.

General and Administrative Expense

For the three months ended September 30, 2020, general and administrative expense was $397, an increase of $203 or 105%, compared to general and administrative expense of $194 in the prior year period. The increase was primarily due to $288 in stock based compensation expense partially offset by decreases in other general overhead expenses compared to the prior year period.

For the nine months ended September 30, 2020, general and administrative expense was $816, an increase of $228, or 39%, compared to general and administrative expense of $588 in the prior year period. The increase in total general and administrative expense is primarily due to the factors discussed for the three month period above.

Other Income and Expense, net

For the three and nine months ended September 30, 2020, other income was $373 and $425, respectively, an increase of $373 and $411, respectively, compared to other income of $0 and $14 for the three and nine months ended September 30, 2019. The increase in other income and expense is due primarily to the forgiveness of $373 and $425, respectively, of accounts payable during the three and nine months ended September 30, 2020. Such forgiveness was generated in conjunction with cash payments of approximately $287. Other income for the three and nine months ended June 30 2019 included the collection of $14 of accounts receivable written off in the prior year.

For the three months ended September 30, 2020, interest expense was $82, an increase of $17, or 24% compared to interest expense of $65 in the prior year period. For the nine months ended September 30, 2020, interest expense was $221, an increase of $33, or 18%, compared to interest expense of $188 in the prior year period. The increase in interest expense is primarily due to the increase in the amount of debt outstanding for the three and nine months ended September 30, 2020 compared to the prior year period.

Amortization of debt discount was $1 and $2 for the three and nine month periods ended September 30, 2020 compared to $10 and $30 in the same periods of the prior year, respectively. The decrease was due to the extension of the maturity date of the Company's debt to December 31, 2020.

Liquidity and Capital Resources

At September 30, 2020, cash and cash equivalents totaled $25, compared to cash and cash equivalents of $25 at December 31, 2019. Net cash used in operating activities was $606. The cash used in operations was offset by $606 in proceeds provided by financing activities. At September 30, 2020, total current assets were $119, compared to total current assets of $108 at December 31, 2019. At September 30, 2020, the Company's principal sources of funds included its aggregated cash and cash equivalents of $25.





                                     - 15 -





                              iSign Solutions Inc.

                    (In thousands, except per share amounts)

                                   FORM 10-Q


Liquidity and Capital Resources (continued)

At September 30, 2020, accounts receivable, net was $63, an increase of $2, or 3%, compared to accounts receivable, net of $61 at December 31, 2019. The increase is due primarily to the timing of billings and collections during the nine months ended September 30, 2020.

At September 30, 2020, prepaid expenses and other current assets were $31, an increase of $9, or 41%, compared to prepaid expenses and other current assets of $22 at December 31, 2019. The increase is due primarily to an increase of prepaids associated with engineering activities during the period.

At September 30, 2020, accounts payable was $350, a decrease of $846, or 71%, compared to accounts payable of $1,196 at December 31, 2019. The decrease is due primarily to the forgiveness of $425 of accounts payable, related cash payments of approximately $287 and the issuance of a note payable of $130 during the three and nine months ended September 30, 2020. At September 30, 2020, accrued compensation was $79, an increase of $8, or 11%, compared to accrued compensation of $71 at December 31, 2019. The increase is due primarily to an increase in accrued vacation expense. Other accrued liabilities were $1,049, an increase of $235, or 29%, from $814 at December 31, 2019 due primarily to the accrual of interest on the Company's short -term debt and deferred professional services.

At September 30, 2020, deferred revenue was $344, a decrease of $2, or 1%, compared to deferred revenue of $346 at December 31, 2019. Deferred revenue primarily reflects advance payments for maintenance fees from the Company's licensees that are generally recognized as revenue by the Company when all obligations are met or over the term of the maintenance agreement, whichever is longer. Deferred revenue is recorded when the Company receives advance payment from its customers.

At September 30, 2020, total current liabilities were $4,681, an increase of $8, or 0.02%, compared to total current liabilities of $4,673 at December 31, 2019.

In January and March 2020, the Company received, from affiliates, advances aggregating $75 in cash against certain accounts receivable of the Company. Upon collection of an invoice, the Company agreed to repay the advance to the lenders on a pro rata basis together with a 5% advance fee. On March 25, 2020, the affiliates converted their advances into unsecured notes. The Company paid the advance fees of $4 in cash, and recorded them as interest expense in the quarter ended March 31, 2020.

In August and September 2020, the Company received, from two affiliates, advances aggregating $83 in cash against certain accounts receivable of the Company. Upon collection of an invoice, the Company agreed to repay the advance to the lenders on a pro rata basis together with a 5% advance fee. The Company has accrued the advance fees of $4 which is included in interest expense in the quarter ended September 30, 2020.

On March 25, 2020, the Company issued an aggregate of $150 in unsecured notes to affiliates and other investors. The Company received $75 in cash and $75 in exchange for the advances discussed above. The unsecured notes are convertible by the holder into common stock at any time at a price per share of $0.50. Upon closing a new financing of at least $1,000 in aggregate proceeds, the Company can force conversion at a price equal to the lesser of $0.50 per share or the price per share of the new financing. The notes bear interest at the rate of 10% per annum and are due December 31, 2020.





                                     - 16 -





                              iSign Solutions Inc.

                    (In thousands, except per share amounts)

                                   FORM 10-Q


Liquidity and Capital Resources (continued)

On May 6, 2020, the Company received loan proceeds in the amount of approximately $123 under the Paycheck Protection Program ("PPP"). The PPP, established as part of the Coronavirus Aid, Relief and Economic Security Act ("CARES Act"), provides for loans to qualifying businesses for amounts up to 2.5 times of the average monthly payroll expenses of the qualifying business. The Company may apply for the loans and accrued interest forgiven after a period of either eight or twenty-four weeks, as long as the borrower uses the loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and maintains its payroll levels. The amount of loan forgiveness will be reduced if the borrower terminates employees or reduces salaries during the period in question. Under the terms of the related promissory note, the unforgiven portion of the PPP loan is payable over two years at an interest rate of 1%, with a deferral of payments for the first six months. The Company used the proceeds for purposes consistent with the PPP. While the Company currently believes that its use of the loan proceeds, for the most part, meets the conditions for forgiveness of the loan, we cannot assure you that we did not take actions that caused the Company to be ineligible for forgiveness of the loan, in whole or in part.

On June 19, 2020, the Company entered into a Note Purchase Agreement (the "Purchase Agreement") with an investor. Under the terms of the Purchase Agreement, the Company received a cash loan in the aggregate amount of $250,000 (the "Loan") from the investor in exchange for the Company's issuance of an unsecured convertible promissory note equal to the amount of such investor's loan contribution to the Company. The Note bears interest at the rate of 10% per annum, and has a maturity date the earlier of December 31, 2021, or the date on which the Company's other outstanding unsecured convertible promissory notes are due. The Note may be converted by its terms at the option of the investor into shares of the Company's common stock.

On July 1, 2020 the Company entered into a settlement agreement with one of its vendors where by the Company paid $135 in cash and issued a promissory note in the amount of $130 in settlement of approximately $537 in outstanding accounts payable. The note bears interest at the rate of 4% per annum and is due in installments of $40, $45 and $45 on or before the anniversary date of the note over the next three years. The settlement agreement discussed above resulted in gain of $272 recorded as other income in the statement of operations.

The Company accrued $83 and $221 of interest expense during the three and nine months ended September 30, 2020, $73 and $194, respectively, associated with the outstanding secured and unsecured convertible promissory notes, of which $28 and $76, respectively, was to related parties and $45 and $118, respectively, was to other investors. For the three and nine months ended September 30, 2019, the Company accrued $65 and $188 of interest expense, $55 and $162, respectively, associated with its outstanding notes, of which $19 and $47, respectively, was to related parties and $36 and $115, respectively, was to other investors.

The Company recorded $1 and $2 in debt discount amortization for the three and nine months ended September 30, 2020. For the three and nine months ended September 30, 2019 the Company recorded $10 and $30 of debt discount

The Company had no material commitments as of September 30, 2020.

The Company has experienced recurring losses from operations that raise a substantial doubt about its ability to continue as a going concern. There can be no assurance that the Company will have adequate capital resources to fund planned operations or that any additional funds will be available to it when needed, or if available, will be available on favorable terms or in amounts required by it. If the Company is unable to obtain adequate capital resources to fund operations, it may be required to delay, scale back or eliminate some or all of its operations, which may have a material adverse effect on the Company's business, results of operations and ability to operate as a going concern.





                                     - 17 -





                              iSign Solutions Inc.

                    (In thousands, except per share amounts)

                                   FORM 10-Q

© Edgar Online, source Glimpses